Erythropoietin in patients with acute coronary syndrome and its cardioprotective action after percutaneous coronary intervention

Circulation Journal

Volumn 73, Issue 10, 2009, Pages 1920-1926

  Nakamura, Reo ^a   Takahashi, Akihiko ^b   Yamada, Takeshi ^a   Miyai, Nobuyuki ^a   Irie, Hidekazu ^a   Kinoshita, Noriyuki ^a   Sawada, Takahisa ^c   Azuma, Akihiro ^d   Matsubara, Hiroaki ^c  

^a Koseikai Takeda Hospital   (Japan)

^b Sakurakai Takahashi Hospital   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d National Shiga Hospital   (Japan)

Author keywords

Acute coronary syndrome; Cardiac function; Erythropoietin

Indexed keywords

ERYTHROPOIETIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART PROTECTION; HORMONE BLOOD LEVEL; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; ERYTHROPOIETIN; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION; VENTRICULAR FUNCTION, LEFT;

EID: 70349869221     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0219     Document Type: Article

References (36)

1. Bolognese L, Neskovic AN, Parodi G, Parodi G, Cerisano G, Buonamici P, et al. Left ventricular remodeling following primary coronary angioplasty: Patterns of left ventricular dilation and long-term prognostic implications. Circulation 2002; 106: 2351-2357. (Pubitemid 35244737)
2. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: Experimental observations and clinical implications. Circulation 1990; 81: 1161-1172. (Pubitemid 20119612)
3. Zijlstra F, de Boer MJ, Hoorntje JCA, Reiffers S, Reiber J, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680-684. (Pubitemid 23073369)
4. Zijlstra F, Hoorntje JCA, de Boer MJ, Reiffers S, Miedema K, Ottervanger JP, et al. Long-term benefits of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999; 341: 1413-1419. (Pubitemid 29513456)
5. Tani S, Nagao K, Watanabe I, Kikushima K, Watanabe K, Anazawa T, et al. Increasingly well-preserved left ventricular function in hospital survivors with acute myocardial infarction. Circ J 2001; 71: 180-185.
6. Jelkmann W. Erythropoietin: Structure, control of production, and function. Physiol Rev 1992; 72: 449-489.
7. Siren AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 2001; 98: 4044-4049. (Pubitemid 32249895)
8. Celik M, Gokmen N, Erbayraktar S, Akhisaroglu M, Konakc S, Ulukus C, et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA 2002; 99: 2258-2263. (Pubitemid 34169048)
9. Grimm C, Wenzel A, Groszer M, Mayser H, Seeliger M, Samardzija M, et al. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 2002; 8: 718-724. (Pubitemid 34778725)
10. Ogilvie M, Yu X, Nicolas-Metral V, Pulido SM, Liu C, Ruegg UT, et al. Erythropoietin stimulates proliferation and interferes with differentiation of myoblast. J Biol Chem 2000; 275: 39754-39761. (Pubitemid 32059005)
11. Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci USA 2003; 100: 4802-4806. (Pubitemid 36457809)
12. Parsa CJ, Matsumoto A, Kim J, Riel RU, Pascal LS, Walton GB, et al. A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest 2003; 112: 999-1007. (Pubitemid 38056315)
13. Silverberg DS, Wexler D, Sheps D, Blum M, Keren G, Baruch R, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: A randomized controlled study. J Am Coll Cardiol 2001; 37: 1775-1780. (Pubitemid 32499958)
14. Mancini DM, Katz SD, Lang CC, LaManca J, Hudaihed A, Androne ASA. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 2003; 107: 294-299. (Pubitemid 36135227)
15. Cai H, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H, et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 2003; 108: 79-85. (Pubitemid 36859024)
16. Parsa CJ, Kim J, Riel RU, Pascal LS, Thompson RB, Petrofski JA, et al. Cardioprotective effects of erythropoietin in the reperfused ischemic heart: A potential role for cardiac fibroblasts. J Biol Chem 2004; 279: 20655-20662. (Pubitemid 38656460)
17. Namiuchi S, Kagaya Y, Ohta J, Shiba N, Sugi M, Oikawa M, et al. High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention. J Am Coll Cardiol 2005; 45: 1406-1412. (Pubitemid 40615610)
18. Ferrario M, Massa M, Rosti V, Campanelli R, Ferlini M, Marinoni B, et al. Early haemoglobin-independent increase of plasma erythropoietin levels in patients with acute myocardial infarction. European Heart Journal 2007; 28: 1805-1813. (Pubitemid 47236646)
19. Figueroa YG, Chan AK, Ibrahim R, Tang Y, Burow ME, Alam J, et al. NF-κB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression. Exp Hematol 2002; 30: 1419-1427.
20. Lin Y, Brown L, Hedley DW, Barber DL, Benchimol S. The death-promoting activity of p53 can be inhibited by distinct signaling pathways. Blood 2002; 100: 3990-4000. (Pubitemid 35396865)
21. Wojchowski D, Gregory RC, Miller CP, Pandit AK, Pircher TJ. Signal transduction in the erythropoietin receptor system. Exp Cell Res 1999; 253: 143-156.
22. Ihle JN. Cytokine receptor signalling. Nature 1995; 377: 591-594.
23. Paffett-Lugassy N, Zon LI. Epo-EpoR signaling not required for cardiovascular or neural development. Blood 2002; 100: 2277.
24. Bolli R, Bhatti ZA, Tang XL, Qiu Y, Zhang Q, Guo Y, et al. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res 1997; 81: 42-52. (Pubitemid 27272981)
25. Matsui T, Tao J, Del Monte F, Lee KH, Li L, Picard M, et al. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 2001; 104: 330-335. (Pubitemid 32666956)
26. Becke LC, Ambrosio G. Myocardial consequences of reperfusion. Prog Cardiovasc Dis 1987; 30: 23-44.
27. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996; 79: 949-956. (Pubitemid 26359236)
28. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Investig 1996; 74: 86-107. (Pubitemid 26041012)
29. Veinot JP, Gattinger DA, Early F. Apoptosis in human myocardial infarcts. H Hum Pathol 1997; 28: 485-492.
30. Lin X, Fujita M, Kanemitsu N, Kimura Y, Tambara K, Goditha UP, et al. Sustained-release erythropoietin ameliorates cardiac function in infarcted rat-heart without inducing polycythemia. Circ J 2007; 71: 132-137. (Pubitemid 46049735)
31. Belonje AM, Westenbrink BD, Voors AA, von Haehling S, Ponikowski P, Anker SD, et al. Erythropoietin levels in heart failure after an acute myocardial infarction: Determinants, prognostic value, and the effects of captopril versus losartan. Am Heart J 2009; 157: 91-96.
32. Donald SS, Dov W, Miriam B, Adrian I, David S, Gad K, et al. Erythropoietin in heart failure. Semin Nephrol 2005; 25: 397-403.
33. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203. (Pubitemid 24203680)
34. Assmus B, Schächinger V, Teupe C, Britten M, Lehmann R, Döbert N, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-3017. (Pubitemid 35440281)
35. Tatsumi T, Ashiwara E, Yasui T, Matsunaga S, Kido A, Sawada Y, et al. Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction. Circ J 2007; 71: 1199-1207. (Pubitemid 47201778)
36. van der Meer P, Voors AA, Lipsic E, Smilde TD, van Gilst WH, van Veldhuisen DJ. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure. J Am Coll Cardiol 2004; 44: 63-67. (Pubitemid 38968458)